Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Bottom
Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ICAAC 2002 published Mon, Nov 10, 2008 - 15:27 EST

ICAAC 2002

icaac_logo_1913587137_3.jpg

Name Type Description
Population Pharmacokinetics (PK) of Linezolid in Neonates and Young Infants PDF Page Primary Author: Minh Vo
Population Pharmacodynamic Assessment of Atazanavir (BMS-232632) Exposure, Genotype, and Safety PDF Page Primary Author: Edward O'Mara, BMS; Primary Cognigen Author: Brenda Cirincione
The Application of Monte Carlo Simulation to the Estimation of Susceptibility Breakpoints PDF Page Primary Author: Paul G. Ambrose
Pharmacodynamic Comparisons of Different Dosing Regimens of Penicillin G Against Penicillin-Susceptible and -Resistant Pneumococci PDF Page Primary Author: Paul G. Ambrose
Monte Carlo Simulation and New Cefotaxime, Ceftriaxone, and Cefepime Susceptibility Breakpoints for S. pneumoniae, Including Strains with Reduced Susceptibility to Penicillin PDF Page Primary Author: MN Dudley; Primary Cognigen Author: PG Ambrose
A Novel Application of Monte Carlo Simulation to Compare PK-PD Target Attainment Rates for Oral Time-Dependent Antimicrobial Regimens PDF Page Primary Author: Paul G. Ambrose
Impact of Pharmacokinetic and Microbiological Variability on the Pharmacodynamics of Gatifloxacin against S. pneumoniae in Children PDF Page Primary Author: Christopher M. Rubino
Use of Monte Carlo Simulation to Evaluate the Antibacterial Activity of Garenoxacin Against Gram-Positive Bacteria PDF Page Primary Author: Paul G. Ambrose
Page authored by Cognigen Corporation

Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ICAAC 2002 published Mon, Nov 10, 2008 - 15:27 EST
Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Top